Edi Dharmana
Department of Parasitology, Faculty of Medicine, Diponegoro University

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

The role of fluoxetine on macrophage function in chronic pain (Experimental study in Balb/c mice) Dwi Pudjonarko; Edi Dharmana; OS Hartanto
International Journal of Science and Engineering Vol 9, No 1 (2015)
Publisher : Chemical Engineering Diponegoro University

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (651.319 KB) | DOI: 10.12777/ijse.9.1.27-33

Abstract

Chronic pain raises stress conditions such as depression that can lower the cellular immunity. Fluoxetine is an antidepressant  used as an adjuvant in pain management but no one has been linked it with the body immune system. The objectives of this research were to proof the benefits of fluoxetine in  preventing degradation of macrophage function in chronic pain by measuring the macrophage phagocytic index , macrophage NO levels and the liver bacterial count in BALB/c mice infected with Listeria Monocytogenes.A Post Test - Only Control Group Design was conducted using 28 male mice strain BALB /c, age 8-10 weeks. The control group (C), mice got the same standard feed as the other groups. Chronic pain group (P), mice were injected with 20μL intraplantar CFA on day-1. Pain + fluoxetine early group (PFE) were treated with P + fluoxetine 5 mg / kg ip day-1, the 4th, the 7th and the 10th, while the Pain + fluoxetine late group (PFL) were treated with P + fluoxetine 5 mg / kg ip on day 7th and 10th. All mice were injected with 104 live Listeria monocytogenes iv on day 8th. Termination was performed on day 13th. Differences within groups  were analyzed using  One-way ANOVA and Kruskall Wallis, whereas the correlation of variables were analyzed using  Pearson's product moment. The experimental results showed that The macrophage phagocytic index and NO macrophage level (pg/mL) in PFE group(2,24±1,013; 0,24±0,239) was higher than than P group (1,68±0,920; 0,21±0,263) and there was no different in the macrophage phagocytic index of PFE group compared to C group (p=0,583; p=0,805). In PFL group (4,32±1,459; 0,54±0,294) the macrophage phagocytic index as well as NO macrophage level (pg/mL) was higher than P group (1,68±0,920; 0,21±0,263) with p=0,002; p=0,017. P group Bacterial count (log cfu/gram) (2,30±0,849) was significantly higher than C group(1,15±0,223) (p=0,007), while PFE group bacterial count (1,96±0,653) and PFL group bacterial count (1,84±0,403) compared to C (1,15± 0,223) was not significantly different (p=0,093; p=0,220). Correlation found between macrophage phagocytic index and macrophage NO (r=0,515, p=0,005).Macrophage phagocytic index and macrophage NO showed no correlation with bacterial count (r=-0,051, p=0,798; r=-0,071, p=0,719).It can be concluded that fluoxetine significantly incerases macrophage phagocytosis index and macrophages NO level in mice with chronic pain,  on the other hand fluoxetine decreases liver bacterial count . There is a positive correlation between macrophage phagocytosis index and macrophages NO level, while no correlation observed  among two variables with mice liver bacterial count in chronic pain.
Typhonium flagelliforme decreases tyrosine kinase and Ki67 expression in mice Chodidjah Chodidjah; Edi Dharmana; Hardhono Susanto; Sarjadi Sarjadi
Universa Medicina Vol. 32 No. 3 (2013)
Publisher : Faculty of Medicine, Universitas Trisakti

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18051/UnivMed.2013.v32.146-154

Abstract

Background Worldwide, breast cancer is the most frequent cancer in women after lung cancer. Treatments include surgery, radiation, immunotherapy and chemotherapy, but are not effective. Tyrosine kinase and Ki67 protein are markers of proliferation. Typhonium flagelliforme ethanol extract (TFEE) has been shown to inhibit proliferation of Michigan Cancer Foundation-7 (MCF7) cells in culture. The aim of the present study was to examine the effect of administration of TFEE on tyrosine kinase and Ki67 expression in mice. Methods This experimental study using post test randomized design with control group was conducted in 24 tumor-bearing CH3 mice. They were randomly divided into 4 groups, consisting of one control and 3 treatment groups (TI, T2, T3) treated daily for 30 days with 0.2 ml TFEE at dosages of 200, 400, and 800 mg/kgBW, respectively. On day 31 the tumor tissues were collected and their tyrosine kinase and Ki67 expression were levels assessed using ELISA and immunohistochemical staining, respectively. Tyrosine kinase and Ki67 expression levels were analyzed, respectively using Kruskal Wallis test and one-way Anova followed by Bonferroni post hoc test. Results Mean tyrosine kinase level was highest in the control group, followed by T3, T2 and T1 (p=0.019). Mean level of Ki 67 expression was highest in the control group, followed by T2, T3 and T1 (p=0.000). Conclussions Oral administration of TFEE at a dose of 200 mg/kgBW decreases tyrosine kinase levels and Ki 67 expression.